###begin article-title 0
Elimination of background recombination: somatic induction of Cre by combined transcriptional regulation and hormone binding affinity
###end article-title 0
###begin p 1
###xml 95 117 95 117 <email xmlns:xlink="http://www.w3.org/1999/xlink">djw@mole.bio.cam.ac.uk</email>
To whom correspondence should be addressed. Tel: +44 1223 336909; Fax: +44 1223 763231; Email: djw@mole.bio.cam.ac.uk
###end p 1
###begin p 2
###xml 444 447 444 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 452 455 452 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 502 505 502 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 507 508 507 508 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T</sup>
###xml 806 809 806 809 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 811 812 811 812 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T</sup>
###xml 1035 1038 1035 1038 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 1040 1041 1040 1041 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T</sup>
###xml 366 371 <span type="species:ncbi:10090">mouse</span>
###xml 1042 1046 <span type="species:ncbi:10090">mice</span>
Somatically inducible Cre lines are used extensively to study gene function. However, a background level of spontaneous recombination due to unregulated expression of Cre is particularly confounding for cancer models in which following the pathogenesis of the disease requires the introduction of sporadic mutations that are monitored over time. In three transgenic mouse lines, two with Cre activity controlled at the transcriptional level (Ahcre, Mx1cre), and one controlled at the protein level (R26creERT), we have identified sporadic recombination at the R26R reporter locus in multiple tissues. Detailed analysis of the intestinal epithelium suggests that recombination can occur both during development and as an ongoing process in adult life. Here we present a new inducible Cre transgenic line, AhcreERT, in which control of Cre activity is regulated at two levels: by transcriptional control of the Ah promoter and by a requirement for Tamoxifen binding. There is no detectable background intestinal recombination in adult AhcreERT mice on the R26R background. Inducible and dose-dependent recombination can be achieved by a single combined treatment with beta-napthoflavone and Tamoxifen.
###end p 2
###begin title 3
INTRODUCTION
###end title 3
###begin p 4
###xml 174 181 174 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 183 184 183 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnh090c1">1</xref>
###xml 185 186 185 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnh090c2">2</xref>
###xml 345 346 345 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnh090c3">3</xref>
###xml 875 878 875 878 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 1020 1021 1020 1021 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnh090c4">4</xref>
###xml 1022 1023 1022 1023 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnh090c5">5</xref>
###xml 1101 1102 1101 1102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnh090c6">6</xref>
###xml 1277 1278 1277 1278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnh090c7">7</xref>
###xml 1279 1280 1279 1280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnh090c8">8</xref>
###xml 1345 1348 1345 1348 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 1399 1400 1399 1400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnh090c9">9</xref>
###xml 102 106 <span type="species:ncbi:10090">mice</span>
The use of site-specific recombinases temporally and spatially to engineer specific gene mutations in mice has become a widely used research tool to understand gene function in vivo (1,2). The use of tissue-specific promoters to regulate Cre recombinase has allowed the study of genes which are 'embryonic lethal' when mutated in the germ line (3). However, even tissue-specific expression involves the introduction of mutations from the earliest stage at which the promoter is active, often before the relevant tissue has fully matured. Both germ-line, and possibly tissue-specific, gene mutations may allow for adaptive responses in which other gene products or pathways modify the response of the tissue over time. A second generation of strategies has focussed on controlling the timing of recombination. Broadly, there are two approaches: (i) to induce transcription of cre and (ii) to regulate the activity of Cre fusion proteins using mutant hormone-binding domains that bind synthetic ligands such as Tamoxifen (4,5). Transcriptional regulation has been reported with the interferon promoter (6) and the tet on/tet off systems in which a chimeric transactivator initiates/represses transcription from a promoter containing the tet operon in the presence of doxycyline (7,8). More recently, we have reported transcriptional regulation of cre using a xenobiotic responsive (CYP 1A1) promoter (9).
###end p 4
###begin p 5
###xml 241 243 241 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnh090c10">10</xref>
###xml 244 246 244 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnh090c12">12</xref>
###xml 313 320 313 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ</italic>
###xml 388 390 388 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnh090c13">13</xref>
Developing these approaches demands a compromise between the level of unwanted background recombination and that induced upon treatment. For example, a common feature of many models is incomplete recombination resulting in tissue mosaicism (10-12). The starting point for the analysis of such tissues is based on in situ methods such as laser capture microscopy and immunohistochemistry (13). Any level of background recombination creates the likelihood that such analyses will include tissue predating Cre induction. This is potentially confounding because cells may over time become functionally adapted to altered patterns of gene expression. Further, in disease models where latency is involved, the respective contribution of pre-existing background and regulated genetic modification is important to define. This applies particularly to cancer models where the aim is to recapitulate the natural history of the disease by introducing a low frequency of sporadic gene mutations at a defined time or location and to follow the development of resultant pathologies.
###end p 5
###begin p 6
###xml 60 63 60 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 458 461 458 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 493 496 493 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 498 499 498 499 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T</sup>
###xml 692 695 692 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 697 698 697 698 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T</sup>
###xml 915 918 915 918 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 920 921 920 921 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T</sup>
###xml 922 926 <span type="species:ncbi:10090">mice</span>
Having determined that the extent of recombination in the Ahcre line is dose dependent and therefore had the potential to allow induction of sporadic gene mutation, we also identified that there was a low level of spontaneous background recombination. Here we describe the frequency and distribution of that background. For comparative purposes we show that similar levels of background recombination are a feature of both the transcriptionally regulated Mx1cre and the Tamoxifen inducible R26creERT lines and are therefore likely to be a feature of most inducible lines in which there is a single controlling element to regulate Cre. As an alternative we have generated a transgenic line, AhcreERT, in which Cre activity is both transcriptionally regulated by the Ah promoter and dependent on Tamoxifen binding to mediate cytoplasmic-nuclear translocation. We show that background recombination is eliminated in AhcreERT mice and that inducible recombination is obtained in tissues in which the Ah promoter is conditionally active.
###end p 6
###begin title 7
MATERIALS AND METHODS
###end title 7
###begin title 8
Genetically modified animals
###end title 8
###begin p 9
###xml 8 11 8 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 13 14 13 14 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnh090c6">6</xref>
###xml 19 22 19 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 24 25 24 25 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnh090c9">9</xref>
###xml 34 37 34 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 40 41 40 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T</sup>
###xml 43 44 43 44 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnh090c5">5</xref>
###xml 71 74 71 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 152 156 152 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lacZ</italic>
###xml 158 160 158 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnh090c14">14</xref>
###xml 171 173 171 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnh090c15">15</xref>
###xml 274 277 274 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 338 341 338 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 403 406 403 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 408 409 408 409 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T</sup>
###xml 540 542 540 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnh090c14">14</xref>
###xml 46 50 <span type="species:ncbi:10090">mice</span>
###xml 94 98 <span type="species:ncbi:10090">mice</span>
Male Mx1cre (6), Ahcre (9) and R26cre-ERT (5) mice were bred to female cre-activated reporter mice in which the reporters, R26R and R26yfp, were either lacZ (14) or EYFP (15), respectively. Transgenic animals were genotyped by PCR using the following primer combinations. Ahcre: 5'-CCTGACTAGCATGGCGATAC-3', 5'-ATTGCCCCTGTTTCACTATC-3'. Mx1cre: 5'-TTTCGTTTCTGAGCTCCTTTC-3', 5'-ATTGCCCCTGTTTCACTATC-3'. R26creERT: 5'-TGACCGTACACCAAAATTTG-3', 5'-ATTGCCCCTGTTTCACTATC-3'. R26R and R26yfp reporter strains were genotyped as described previously (14) and double transgenic animals selected for further analysis. Animals were maintained in a specific pathogen-free facility and all animal procedures were carried out under the authority of a UK project licence, the awarding of which includes an ethical review process.
###end p 9
###begin p 10
###xml 15 18 15 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 20 21 20 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T</sup>
###xml 51 54 51 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 67 68 67 68 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T</sup>
###xml 95 97 95 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnh090c16">16</xref>
###xml 178 181 178 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 183 184 183 184 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T</sup>
###xml 193 196 193 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 198 199 198 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnh090c9">9</xref>
###xml 204 207 204 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bgl</italic>
###xml 217 220 217 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 222 223 222 223 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T</sup>
###xml 548 551 548 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 553 554 553 554 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T</sup>
###xml 59 64 <span type="species:ncbi:10090">mouse</span>
The plasmid pAhcreERT, containing a fusion gene of cre and mouse ERT [with the G525R mutation (16) in the ligand-binding domain to promote Tamoxifen binding] was made by cloning creERT into pAhcre (9) by BglII. The AhcreERT expression cassette was released by NotI digestion and transgenic founder animals generated by pronuclear microinjection of CBAxC57BL/6 F1 oocytes. Two founder animals were obtained which gave germ-line transmission and both behaved identically in functional assays in crosses to reporter lines (data not shown). One line AhcreERT was selected for all subsequent experiments and was bred to homozygosity after breeding on a C57BL/6J background for three to four generations.
###end p 10
###begin p 11
###xml 4 7 4 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 64 67 64 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 69 70 69 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T</sup>
###xml 75 78 75 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 82 85 82 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 92 95 92 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 97 98 97 98 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T</sup>
###xml 241 244 241 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 246 247 246 247 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T</sup>
###xml 108 112 <span type="species:ncbi:10090">mice</span>
###xml 253 257 <span type="species:ncbi:10090">mice</span>
###xml 397 401 <span type="species:ncbi:381124">corn</span>
The cre transgenic animals were crossed to reporter animals. R26creERT, Mx1cre, Ahcre and AhcreERT reporter mice received no treatment but were killed for determination of background recombination frequencies between 6 and 8 weeks of age. AhcreERT/R26R mice at 6-8 weeks of age were treated with two intraperitoneal injections given less than 1 h apart of beta-napthoflavone (betaNF) dissolved in corn oil (8 mg/ml) followed by Tamoxifen (10 mg/ml) in sunflower oil and killed at the times stated. The dose administered ranged from 8 to 80 mg/kg of betaNF and 0.01 to 1 mg of Tamoxifen.
###end p 11
###begin title 12
###xml 13 16 13 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
Detection of cre-mediated recombination
###end title 12
###begin p 13
###xml 17 21 17 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lacZ</italic>
###xml 393 394 380 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnh090c9">9</xref>
###xml 975 976 961 962 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnh090c9">9</xref>
###xml 1114 1117 1100 1103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 1119 1120 1105 1106 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T</sup>
###xml 1125 1128 1111 1114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 1135 1138 1121 1124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 1510 1513 1496 1499 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 1515 1516 1501 1502 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T</sup>
For detection of lacZ expression tissues were fixed in ice-cold 2% formaldehyde/0.2% glutaraldehyde in phosphate-buffered saline (PBS) (pH 7.4) for 2-6 h, equilibrated in 20% sucrose/PBS then frozen in liquid nitrogen prior to storage at -80degreesC. Cryostat sections were cut at 10-15 mum and air dried prior to histochemical detection of beta-galactosidase (beta-gal) with X-gal substrate (9). Tissues selected for analysis were sectioned at three different levels (with each level being separated by at least 200 mum) and at each level multiple sections were collected onto each slide for X-gal staining. The following tissues were analysed, and were primarily chosen to give good coverage of the principal epithelia: liver, gall bladder, pancreas, fore stomach, glandular stomach, oesophagus, tongue, kidney, bladder, lung and heart. Recombination in small intestine and colon was identified in intestinal wholemounts, prepared luminal side up, as described previously (9). Wholemount preparations were examined using a standard dissecting microscope. For quantification of background recombination in the R26creERT, Mx1cre and Ahcre lines the entire length of stained wholemounts was scored by cutting it into strips up to 5 cm long, mounting on a microscope slide abluminal side up and examined using a Nikon Optiphot2. Stained crypts were scored (total magnification of 250x) and categorized as being wholly or partially stained and the patch size (number of crypts per patch) also recorded. For the AhcreERT dose-response experiments a 5 cm length of intestine taken from 25% of the length of the small intestine from the pylorus was scored.
###end p 13
###begin title 14
Flow cytometric analysis
###end title 14
###begin p 15
###xml 370 371 369 370 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 402 403 401 402 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 413 414 412 413 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
Spleens and femurs were transferred immediately into air-buffered DMEM containing 5% FCS. Spleens were disaggregated by passage through a 45 mum cell strainer (Falcon). Bone marrow was removed from femurs by flushing. Cells were recovered by centrifugation, washed with media and resuspended in PBS with 0.5% BSA and 0.05% sodium azide at a final concentration of 2 x 107 cells/ml. Fluorescence (5 x 105 to 5 x 106 cells per sample) was measured with a FACSCalibur flow cytometer (Becton-Dickinson, San Jose, CA) over FL-1 (530 +/- 15 nm) and FL-2 (585 +/- 21 nm) channels. Scatter plots were analysed using Cellquest software (Becton-Dickinson, San Jose, CA), gating was set using cell preparations from animals not containing the EYFP transgene.
###end p 15
###begin title 16
RESULTS
###end title 16
###begin title 17
###xml 37 40 37 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 42 43 42 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T</sup>
###xml 47 50 47 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 53 56 53 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
Background recombination in adult R26creERT/Mx1cre/Ahcre animals
###end title 17
###begin p 18
###xml 14 17 14 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 133 134 133 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnh090c5">5</xref>
###xml 135 136 135 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnh090c6">6</xref>
###xml 137 138 137 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnh090c9">9</xref>
###xml 302 305 302 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
For all three cre lines the background level of spontaneous recombination has been described previously but using different methods (5,6,9). We utilized the constitutive reporter gene expression obtained from the recombinant R26R locus to undertake an assessment of spontaneous recombination events in cre-R26R double transgenic animals by X-gal staining of adult tissues.
###end p 18
###begin p 19
###xml 32 35 32 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 37 38 37 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T</sup>
###xml 101 102 101 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gnh090f1">1</xref>
###xml 244 245 244 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gnh090f1">1</xref>
###xml 278 279 278 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gnh090f1">1</xref>
###xml 347 348 347 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gnh090f1">1</xref>
###xml 437 440 437 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 493 494 493 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gnh090f1">1</xref>
###xml 712 713 712 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gnh090f1">1</xref>
###xml 938 941 938 941 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 1044 1045 1044 1045 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gnh090f1">1</xref>
###xml 1176 1177 1176 1177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gnh090f1">1</xref>
###xml 1241 1242 1241 1242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gnh090f1">1</xref>
###xml 1031 1035 <span type="species:ncbi:10090">mice</span>
As described previously, the R26creERT showed most recombination in proximal small intestine (Figure 1A) which was also frequently observed, with numerous blue recombinant cells in each section, in liver, gall bladder, kidney, pancreas (Figure 1B) and glandular stomach (Figure 1C) and to a lesser extent in fore stomach, oesophagus, lung (Figure 1D), heart and bladder. Very little recombination was observed in tongue or colon. The Mx1cre line shows extensive recombination in liver (Figure 1E), kidney and pancreas in which many recombinant cells were observed in each tissue section. Other tissues showing a lower level of recombination, with only occasional blue cells, were small intestine, tongue (Figure 1F), skin, bladder, oesophagus, fore stomach and heart. Very little recombination was observed in colon and glandular stomach with some sections showing no recombinants and only the occasional recombinant cell in others. In Ahcre animals there was extensive recombination in the cardiac muscle and kidneys of untreated mice (Figure 1G and H). There was a significant level of background recombination in bladder and to a lesser extent oesophagus and liver (Figure 1I). Recombination in glandular stomach, small intestine (Figure 1J), colon, tongue and pancreas was only occasionally observed.
###end p 19
###begin title 20
Background recombination in spleen and bone marrow
###end title 20
###begin p 21
###xml 118 121 118 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 136 137 136 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gnh090f1">1</xref>
###xml 195 198 195 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 249 250 243 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 350 353 344 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 355 356 349 350 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T</sup>
###xml 398 399 388 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 431 434 421 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 479 480 465 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 550 553 536 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 94 98 <span type="species:ncbi:10090">mice</span>
###xml 357 361 <span type="species:ncbi:10090">mice</span>
Background recombination in spleen and bone marrow was measured in cells isolated from R26yfp mice crossed onto three cre lines (Figure 1K-O). The most extensive recombination was observed in Mx1cre [3.19% +/- 0.89 and 4.79% +/- 0.83 (mean +/- SE), n = 6 for bone marrow and spleen, respectively]. There was a much lower level of recombination in R26creERT mice (0.26% +/- 0.23 and 0.16% +/- 0.11, n = 7) and effectively none in Ahcre animals (0.0025% +/- 0.0025, 0.07 +/- 0.07, n = 4). The Ah promoter is not active in haematopoietic cells, with no cre expression on induction.
###end p 21
###begin title 22
Measurement of intestinal recombination
###end title 22
###begin p 23
###xml 152 155 152 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 160 163 160 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 172 175 172 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 177 178 177 178 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T</sup>
###xml 345 348 345 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 350 351 350 351 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T</sup>
###xml 359 362 359 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 408 411 408 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 1078 1081 1075 1078 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 1172 1173 1169 1170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gnh090f1">1</xref>
###xml 184 188 <span type="species:ncbi:10090">mice</span>
###xml 520 525 <span type="species:ncbi:10090">mouse</span>
###xml 529 534 <span type="species:ncbi:10090">mouse</span>
To determine the nature and extent of background recombination in the intestinal epithelium, wholemounts of X-gal-stained small intestine from adult Mx1cre-, Ahcre- and R26creERT-R26R mice were prepared. In these preparations a clear spatial pattern of recombination was evident with a proximal-distal gradient of epithelial staining for the R26creERT and Mx1cre lines. This effect was less evident in the Ahcre line due to large clusters of recombinant areas of epithelium which were variable in position and size from mouse to mouse. Staining in all lines was present as patches of blue recombinant epithelium that was contained in intestinal crypts. The size of recombinant patches was variable: large patches of contiguous crypts were observed as well as individual crypts that were partly or wholly occupied by recombinant epithelium. Other tissue components in wholemounts showed frequent positive beta-galactosidase reactivity. These include blood vessels, longitudinal and circular muscle, and a cell type present on the outer surface of the gut (most frequent in the Ahcre line) which we tentatively identify as mesothelial cells of the peritoneal lining (Figure 1A).
###end p 23
###begin p 24
###xml 167 168 167 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gnh090f2">2</xref>
###xml 274 277 272 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 279 280 277 278 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T</sup>
###xml 300 303 296 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 326 329 320 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 393 394 387 388 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 478 481 472 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 483 484 477 478 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T</sup>
###xml 488 491 482 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 499 502 493 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 655 658 649 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 708 711 698 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 713 714 703 704 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T</sup>
###xml 752 755 738 741 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 882 885 864 867 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 974 977 956 959 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 1018 1021 1000 1003 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 1023 1024 1005 1006 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T</sup>
###xml 1032 1035 1014 1017 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 1220 1221 1202 1203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gnh090f2">2</xref>
###xml 886 890 <span type="species:ncbi:10090">mice</span>
Wholemounts were scored for both the total number of crypts containing recombinant epithelium and the size of recombinant patches (number of crypts per patch) (Figure 2A). The mean frequency of recombinant crypts per small intestine for each line was: 11559 (+/-701 SE), R26creERT; 1108 (+/-60 SE) Ahcre and 287 (+/-71 SE) Mx1cre. Taking the total number of crypts per small intestine to be 106, this equates to approximately 12, 1.1 and 0.3% of the total epithelium for the R26creERT, Ahcre and Mx1cre lines respectively. However, the proportion of single (wholly or partly) stained crypts as a percentage of total stained crypts was much lower in the Ahcre line (3.2% +/- 0.35, mean +/- SE) than in the R26creERT (59.7% +/- 14.4, mean +/- SE) and Mx1cre (33.1% +/- 4.26, mean +/- SE) lines. The corollary of this observation must be that a larger proportion of recombination in Ahcre mice is present in multi-crypt patches and indeed the median patch size was 6 for the Ahcre line compared to 2.8 and 4.5 for the R26creERT and Mx1cre lines, respectively. The proximal-distal pattern of staining did not apply to large patches of recombinant crypts which appeared to be randomly distributed along the intestine (Figure 2B-D).
###end p 24
###begin title 25
###xml 14 17 14 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 19 20 19 20 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T</sup>
###xml 21 25 <span type="species:ncbi:10090">mice</span>
Analysis of AhcreERT mice
###end title 25
###begin p 26
###xml 29 32 29 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 34 35 34 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T</sup>
###xml 443 444 440 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 41 45 <span type="species:ncbi:10090">mice</span>
###xml 413 417 <span type="species:ncbi:10090">mice</span>
###xml 751 755 <span type="species:ncbi:10090">mice</span>
Solid tissues of untreated AhcreERT/R26R mice were screened for background recombination by X-gal staining of frozen sections, as described above. In cardiac muscle, kidney, liver, gall bladder, small intestine, pancreas, glandular stomach and oesophagus there was no positive staining for beta-galactosidase. In bladder, two positive cells in total were identified in numerous serial sections from two different mice. Intestinal wholemounts (n = 3) stained with X-gal scored along their entire length showed no beta-galactosidase expression in either the intestinal epithelium or in non-epithelial components of the gut. Flow sorted bone marrow and spleen populations also showed no increase in the frequency of positive cells compared to cells from mice lacking the EYFP reporter (data not shown).
###end p 26
###begin p 27
###xml 8 11 8 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 13 14 13 14 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T</sup>
###xml 453 454 450 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gnh090f3">3</xref>
###xml 573 574 570 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gnh090f3">3</xref>
###xml 760 761 757 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gnh090f3">3</xref>
###xml 20 24 <span type="species:ncbi:10090">mice</span>
Adult AhcreERT/R26R mice were treated with 80 mg/kg betaNF and 1 mg of Tamoxifen and left for 14 days to 6 months post-induction prior to screening for recombination. Animals tolerated the combined treatment very well and displayed no evidence of toxicity either immediately following treatment or in the longer term. After 14 days, extensive sporadic X-gal positive recombinant cells could be observed in the small intestine, liver and bladder (Figure 3A-C), and pancreas (data not shown). Less frequent recombinants were observed in glandular stomach, oesophagus (Figure 3D and E) and gall bladder and fore stomach (data not shown). By 6 months recombinant cells were observed to persist in most of these tissues, including gall bladder and pancreas (Figure 3F and G) although in bladder they were much reduced in frequency and were absent in oesophagus and fore stomach.
###end p 27
###begin p 28
###xml 83 86 83 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 88 89 88 89 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T</sup>
###xml 226 227 223 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gnh090f4">4</xref>
###xml 426 428 420 422 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;5</sup>
###xml 438 440 432 434 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;2</sup>
###xml 688 690 677 679 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;6</sup>
###xml 707 708 694 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 95 99 <span type="species:ncbi:10090">mice</span>
To determine the relationship between inducer dose and recombination, cohorts of AhcreERT/R26R mice were treated with varying doses of betaNF and Tamoxifen and recombination frequency counted in intestinal wholemounts (Figure 4) at 6 weeks post-induction. By varying the dose of betaNF between 8 and 80 mg/kg and of Tamoxifen between 0.01 and 1 mg, the extent of recombination can be varied over a 1000-fold range: from 5 x 10-5 to 5 x 10-2. This dose responsiveness arises from the combined treatment with both inducing agents as no recombination was obtained after treatment with 1 mg Tamoxifen only and after a single dose of 80 mg/kg betaNF a low rate of combination (2.8 +/- 1.8 x 10-6, mean +/- S.E., n = 5) was detected.
###end p 28
###begin title 29
DISCUSSION
###end title 29
###begin p 30
###xml 986 987 986 987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnh090c5">5</xref>
###xml 988 990 988 990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnh090c17">17</xref>
###xml 991 993 991 993 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnh090c18">18</xref>
###xml 1188 1190 1188 1190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnh090c19">19</xref>
There are two types of analyses where the presence of background recombination could confound the interpretation of somatically engineered gene mutations. First, expression arrays generated from microdissected tissues may identify transcriptional changes within functionally adapted mutant cells which predate induction. This is likely where the level of induced recombination is low and the background high. The second example is in cancer studies, where the objective is to model the aetiology and stages of disease progression. Such models require the introduction of sporadic mutations at a defined time to allow the developing pathology to be monitored. There are relatively few methods for introducing defined mutations in this way. They include (i) viral delivery or regulated expression of recombinases and (ii) the introduction of inactivating but unstable genetic elements which allow expression of altered genes following spontaneous mutagenesis or homologous recombination (5,17,18). All methods suffer from some drawbacks either in terms of leaky background, lack of temporal control or, in the case of viruses, immunological/titre problems [see review by Jonkers and Berns (19)].
###end p 30
###begin p 31
###xml 892 895 892 895 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 1339 1342 1339 1342 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 1344 1345 1344 1345 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T</sup>
###xml 1371 1372 1371 1372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gnh090f1">1</xref>
###xml 1377 1378 1377 1378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gnh090f3">3</xref>
The cause of unregulated background recombination presumably arises from either endogenous substrates or ones found in diet. The proximal to distal gradient of recombination in the small intestinal epithelium for the lines studied here may argue that different contaminants of the diet are capable of inducing Cre activity in each case. These dietary elements or their metabolites may be transported to other tissues. However, the proximal-distal effect is associated with a small patch size of the recombinant epithelium. Large patches appear to be randomly placed along the intestine, suggesting that another contributing factor to the extent of background recombination is the expansion of recombinant cells that arise during embryonic development. For each of the three lines there is a different proportion of contribution from such embryonic recombinants. It is most striking for the Ahcre line where it contributes 97% of the total background. Indeed this is probably an underestimation as the spatially restricted clusters of epithelial recombinants include individual crypts which appear associated with adjacent larger patches. In many other tissues the recombinant epithelium often also appears to contain large contiguous patches of recombinant cells. This is particularly evident when comparing with the pattern observed in AhcreERT animals (compare Figures 1 and 3).
###end p 31
###begin p 32
###xml 84 85 84 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnh090c6">6</xref>
###xml 86 88 86 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnh090c14">14</xref>
###xml 89 91 89 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnh090c20">20</xref>
###xml 113 116 113 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 194 195 194 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnh090c9">9</xref>
###xml 217 220 217 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
Both the ROSA26 and Mx1 promoters have a wide range of inducible tissue expression (6,14,20) while that of the Ahcre line is selectively directed to the epithelia of the gastrointestinal tract (9). Thus only in the Ahcre line can the tissue specificity of inducible and background recombination be compared. Clearly, background recombination is greater in some (heart, kidney), but not all (spleen, bone marrow) of those tissues that are not transcriptionally inducible for the Ah promoter in the adult. In fact, the extent of background recombination in the principal adult target tissues, liver and small intestine, is much lower than in heart and kidney. This may suggest that the Ah promoter is promiscuously active in some tissues during development but later becomes more tightly regulated. This interpretation is also consistent with the predominance of large patches of background recombination in the small intestine.
###end p 32
###begin p 33
###xml 6 9 6 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 11 12 11 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T</sup>
###xml 130 133 130 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 455 458 455 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 460 461 460 461 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T</sup>
###xml 782 785 782 785 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 787 788 787 788 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T</sup>
###xml 906 909 903 906 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 916 917 913 914 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnh090c9">9</xref>
###xml 1054 1055 1048 1049 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T</sup>
###xml 462 466 <span type="species:ncbi:10090">mice</span>
###xml 789 793 <span type="species:ncbi:10090">mice</span>
###xml 910 914 <span type="species:ncbi:10090">mice</span>
The AhcreERT line allows induction of Cre-mediated recombination in the absence of any apparent background. The binary control of cre activity, at both transcriptional and protein levels, must provide this tight control. The additional Tamoxifen requirement presumably ensures that there is no unregulated recombination during the promiscuous phase for Ah promoter activity described above, while the extensive intestinal recombination observed in the R26creERT mice is avoided due to the stringent regulation of the Ah promoter in the adult. In all target tissues the pattern of recombination is mosaic and apparently sporadic with individual cells (liver) or amplified clones (small intestine) scattered through the tissue. The frequency of intestinal recombination obtained in AhcreERT mice following a single dose of 80 mg/kg betaNF and 1 mg of Tamoxifen is around 6-fold lower than that observed in Ahcre mice (9) following a single dose of 80 mg/kg betaNF. We ascribe this lower degree of responsiveness largely to a reduced efficiency of the CreERT fusion protein compared to the native recombinase.
###end p 33
###begin p 34
###xml 124 132 124 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 322 324 322 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gnh090c21">21</xref>
###xml 361 368 361 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
The concept of regulating Cre activity with combined transcriptional and protein controls has been described recently in an in vitro study employing a single agent, a progesterone analogue, that binds a transactivor encoded at one transgene to induce expression of a progesterone-responsive Cre fusion protein at another (21). In contrast, the system validated in vivo in this report employs two independent inducing agents acting at a single transgene.
###end p 34
###begin p 35
###xml 210 212 210 212 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;5</sup>
###xml 289 296 289 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ</italic>
###xml 519 521 507 509 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;2</sup>
###xml 524 526 512 514 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;3</sup>
###xml 667 669 655 657 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;2</sup>
###xml 685 686 673 674 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4</sup>
###xml 868 871 856 859 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 873 874 861 862 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T</sup>
The optimal frequency with which a desired mutation is introduced will vary with application. Higher frequencies are needed for microdissection, but in the case of low-level sporadic events a rate lower than 10-5 would seem impracticable in terms of detecting mutant cells or small clones in situ (e.g. in small intestine this would give about 10 mutant crypts per gut distributed along a approximately36 cm length) but might suffice if lesions are allowed to develop to macroscopic size. Equally, levels higher than 10-2-10-3 might reduce the certainty of lesions occurring independently in a wild-type background. Again in small intestine a recombination rate of 10-2 would induce 104 affected crypts per small intestine with a high probability of neighbouring lesions colliding as they reach macroscopic size. The dose-dependent induction of recombination in the AhcreERT line demonstrates the utility of combining control at the transcriptional and protein level to regulate Cre activity in the absence of detectable background. This simple strategy, which could be applied to other transcriptionally inducible promoters, such as that for interferon, will have an application in developing cancer models which recapitulate the sporadic nature of the disease process.
###end p 35
###begin title 36
Figures and Tables
###end title 36
###begin p 37
###xml 35 38 35 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 70 71 70 71 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 78 79 78 79 <bold xmlns:xlink="http://www.w3.org/1999/xlink">J</bold>
###xml 87 88 87 88 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 89 90 89 90 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 95 98 95 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 100 101 100 101 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T</sup>
###xml 104 105 104 105 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E</bold>
###xml 112 113 112 113 <bold xmlns:xlink="http://www.w3.org/1999/xlink">F</bold>
###xml 118 121 118 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 124 125 124 125 <bold xmlns:xlink="http://www.w3.org/1999/xlink">G</bold>
###xml 126 127 126 127 <bold xmlns:xlink="http://www.w3.org/1999/xlink">J</bold>
###xml 131 134 131 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 322 323 322 323 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 336 337 336 337 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 571 572 571 572 <bold xmlns:xlink="http://www.w3.org/1999/xlink">H</bold>
###xml 583 584 583 584 <bold xmlns:xlink="http://www.w3.org/1999/xlink">I</bold>
###xml 750 751 750 751 <bold xmlns:xlink="http://www.w3.org/1999/xlink">K</bold>
###xml 752 753 752 753 <bold xmlns:xlink="http://www.w3.org/1999/xlink">N</bold>
###xml 860 863 860 863 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 865 866 865 866 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T</sup>
###xml 882 885 882 885 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 894 895 894 895 <bold xmlns:xlink="http://www.w3.org/1999/xlink">L</bold>
###xml 900 903 900 903 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 912 913 912 913 <bold xmlns:xlink="http://www.w3.org/1999/xlink">M</bold>
###xml 1038 1039 1038 1039 <bold xmlns:xlink="http://www.w3.org/1999/xlink">O</bold>
###xml 135 139 <span type="species:ncbi:10090">mice</span>
 Background recombination in three cre lines. X-gal stained tissues, (A) and (J) from (A-D) R26creERT; (E) and (F) Mx1cre; (G-J) Ahcre mice crossed onto the R26R strain. (A) Small intestinal wholemount showing stained intestinal crypts (cr) and cells of the peritoneal lining (arrow heads, also shown in section, inset). (B) Pancreas, (C) the glandular region of the stomach, (D) lung, showing isolated positive cells in bronchioles. (E) Liver, (F) tongue showing localized 'patch' of positive epidermal staining (also shown in higher power, inset). (G) Cardiac muscle, (H) kidney, (I) liver, (J) wholemounted strips of intestine showing a localized region of epithelial staining proximally, bracketed (inset, expanded view of part of this region). (K-N) Sample flow cytometric scatter plots for bone marrow cells measured over 530 and 585 nm channels from R26creERT/R26yfp (K), Mx1cre/R26yfp (L), Ahcre/R26yfp (M) and control, R26yfp-negative (N) animals. The number of cells within the gated region (R1) were counted as EYFP positive. (O) Bar chart showing summary flow cytometric data for bone marrow and spleen isolates for the three lines (black boxes, bone marrow; grey boxes, spleen).
###end p 37
###begin p 38
###xml 2 3 2 3 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 92 95 92 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 103 106 103 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 113 116 113 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 314 315 314 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 335 336 335 336 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 337 338 337 338 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 428 431 428 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 433 434 433 434 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T</sup>
###xml 443 446 443 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 448 449 448 449 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 457 460 457 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 741 744 741 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 746 747 746 747 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T</sup>
###xml 755 758 755 758 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 117 121 <span type="species:ncbi:10090">mice</span>
 (A) Frequency of background recombinants at the R26R locus in adult small intestine for R26creERT, Mx1cre and Ahcre mice. Boxes represent the mean totals of partially stained crypts (black), single-stained crypts (dark grey), crypt patches (light grey) and the total recombined crypts of the three types (white). n = 3, bars are SE. (B-D) Distribution of background recombinant patch frequency within the small intestine in R26creERT (B), Mx1cre (C) and Ahcre (D) animals. Frequency of patches less than or equal to four crypts (triangle) or greater than or equal to five crypts (circles) in size are plotted. Linear regression lines for patches less than or equal to four crypts in size showing proximal-distal gradient are plotted for R26creERT and Mx1cre.
###end p 38
###begin p 39
###xml 32 35 32 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 37 38 37 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T</sup>
###xml 132 135 129 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 137 138 134 135 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T</sup>
###xml 184 185 181 182 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 186 187 183 184 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E</bold>
###xml 202 203 199 200 <bold xmlns:xlink="http://www.w3.org/1999/xlink">F</bold>
###xml 210 211 207 208 <bold xmlns:xlink="http://www.w3.org/1999/xlink">G</bold>
###xml 306 307 303 304 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 317 318 314 315 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 330 331 327 328 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 39 43 <span type="species:ncbi:10090">mice</span>
###xml 139 143 <span type="species:ncbi:10090">mice</span>
 Patterns of recombination in AhcreERT mice following induction with beta-napthoflavone and Tamoxifen. X-gal stained tissues from AhcreERT mice crossed onto the R26R strain two weeks (A-E) or 6 months (F) and (G) after induction. (A) Region of small intestine showing a sporadic pattern of recombination; (B) liver; (C) bladder; (D) glandular stomach; (E) oesophagus; (F) gall bladder, showing positive cells; (G) pancreas.
###end p 39
###begin p 40
###xml 44 47 44 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre</italic>
###xml 49 50 49 50 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T</sup>
###xml 320 321 317 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 51 55 <span type="species:ncbi:10090">mice</span>
 Frequency of intestinal recombination in AhcreERT mice alters with dose of inducer. Counts of X-gal positive crypts from intestinal wholemounts prepared 6 weeks after treatment with the doses of beta-napthoflavone and Tamoxifen shown. Zero values were obtained for untreated animals and those receiving Tamoxifen only. n = 5 to 7, bars are SE.
###end p 40
###begin title 41
ACKNOWLEDGEMENT
###end title 41
###begin p 42
This work was funded by Cancer Research UK.
###end p 42
###begin title 43
REFERENCES
###end title 43

